Fortress Biotech Q2 EPS $(0.73) Beats $(1.23) Estimate, Sales $14.90M Beat $14.77M Estimate
Fortress Biotech Q2 EPS $(0.73) Beats $(1.23) Estimate, Sales $14.90M Beat $14.77M Estimate
Fortress Biotech第二季度每股收益为$(0.73)，超过$(1.23)的预估，销售额为1490万美元，超过1477万美元的预估。
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.23) by 40.65 percent. This is a 80 percent increase over losses of $(3.65) per share from the same period last year. The company reported quarterly sales of $14.90 million which beat the analyst consensus estimate of $14.77 million by 0.83 percent. This is a 14.32 percent decrease over sales of $17.39 million the same period last year.
Fortress biotech (纳斯达克:FBIO) 报告每股亏损$(0.73)，超过分析师共识预测$(1.23)的40.65%。这比去年同期每股亏损$(3.65)增长了80%。公司报告季度销售额1490万美元，击败分析师一致预期1477万美元的0.83%。这是去年同期17.39%销售额1739万美元的14.32%下降。